Practice Update: DIABETES

3 / 24

PracticeUpdate is guided by a world-renowned
Editorial and Advisory Board that represents
community practitioners and academic specialists
with cross-disciplinary expertise.
Editor-in-Chief Silvio Inzucchi MD
Associate Editors Richard Pratley MD,
Deborah Wexler MD
Editorial Contributors Lisa Parikh,
Ana Perdigoto MDPhD,
Camille Powe MD
PracticeUpdate® is a registered trademark of Elsevier
Inc. © 2017 Elsevier Inc. All rights reserved.
ABOUT
PracticeUpdate Diabetes provides coverage of key
research from leading international conferences, and
a collection of top journal articles and accompanying
expert commentaries in a convenient print periodical.
These and more are also available online at www.
PracticeUpdate and PracticeUpdate Diabetes
are commercially supported by advertising,
sponsorship, and educational grants. Individual access
to is free. Premium content is
available to any user who registers with the site.
While PracticeUpdate is a commercially-sponsored
product, it maintains the highest level of academic
rigour, objectivity, and fair balance associated with all
Elsevier products. No editorial content is influenced
in any way by commercial sponsors or content
contributors.
DISCLAIMER
PracticeUpdate Diabetes has been developed
for specialist medical professionals. The ideas
and opinions expressed in this publication do not
necessarily reflect those of the Publisher. Elsevier will
not assume responsibility for damages, loss, or claims
of any kind arising from or related to the information
contained in this publication, including any claims
related to the products, drugs, or services mentioned
herein. Because of rapid advances in the medical
sciences, in particular, independent verification
of diagnoses and drug dosages should be made.
Please consult the full current Product Information
before prescribing any medication mentioned in this
publication.
Although all advertising material is expected to
conform to ethical (medical) standards, inclusion in
this publication does not constitute a guarantee or
endorsement of the quality or value of such product or
of the claims made of it by its manufacturer.
SALES
Fleur Gill
Linnea Mitchell-Taverner
PRODUCTION
Editorial Manager Anne Neilson
Editorial Project Manager Carolyn Ng
DesignerJana Sokolovskaja
Cover images:Illustration of glucose and insulin in
the body.
PracticeUpdate Diabetes is
published by Elsevier Australia
ISSN 2208-1488 (Print) ISSN 2208-1496 (Online)
ABN 70 001 002 357
475 Victoria Avenue
Chatswood NSW 2067 Australia
Locked Bag 7500 Chatswood DC NSW 2067
EMED061701
My perspective
20
A resurgence of interest
in pioglitazone?
22
Reading our blueprints
– nature’s lessons in
pathophysiology found
within our DNA
Conference coverage
8
American Association of
Clinical Endocrinologists
26th Annual Meeting &
Clinical Congress
8 Women with gestational
diabetes requiring
insulin at higher risk of
postpartum diabetes
9 Three prognostic factors
of mortality identified in
patients with diabetic
ketoacidosis
10 U500 insulin screening
of diabetic patients
uncovers large amount
of undiagnosed
hypercorticolism consistent
with Cushing’s syndrome
11 Guidelines for treating
the new cardiovascular
“extreme risk” category
have been validated
12 BMI, polypharmacy, lab
testing may help diagnose
DKA and identify high risk
of its recurrence
13 Heart failure deserves more
scrutiny as a complication
of type 2 diabetes
Cover
5
Effect of metformin and
lifestyle on coronary
artery calcium in the
Diabetes Prevention
Program
RESEARCH
Editor’s picks
4 Effect of a virtual glucose
management service on
inpatient glycemic control
5 Effect of metformin and
lifestyle on coronary artery
calcium in the Diabetes
Prevention Program
6 Ophthalmic screening
insufficient among youths
with diabetes
7 Effect of artificial pancreas
systems on glycemic
control in patients with
type 1 diabetes
Microvascular
complications
14 Effects of a long-term
lifestyle modification
program on peripheral
neuropathy in obese adults
with type 2 diabetes
16 Individualized model for
retinopathy screening in
type 1 diabetes
Obesity
17 Artificially sweetened
beverages, stroke and
dementia
Cardiovascular
complications
18 Sulfonylureas are
associated with increased
risks of cardiovascular
events and death
19 Effect of fasting glucose
levels on cardiovascular
disease and all-cause
mortality
CONTENTS 3
VOL. 1 • NO. 1 • 2017 VOL. 2 • . X